Home›Companies›Healthcare›MedWatch

MedWatch Technologies, Inc.

Develops a needle-free wearable to track glucose response for people monitoring their wellness.

Updated Nov 11, 2026·Latest SEC filing Mar 6, 2026·Suggest an edit

About MedWatch

MedWatch is a private company based in Lewes, Delaware, incorporated in 2022 in Delaware. It has reported $17,550,969 raised in one offering on Form D since March 2026. Its chief executive is Sam Zaidspiner.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 11, 2025Mar 6, 2026$17,550,969of $29.4M target118$148KEquity, DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on MedWatch's Form D filed Mar 6, 2026.

Bruce Matichuk
Bruce Matichuk
Co-Founder & CTO - Advanced Research, director
Mike Moore
Mike Moore
Founder & Chairman
Peter Light
Peter Light
Co-Founder & Chief Science Officer, director
AT
RV
VA
Virender Ahuwalia
Executive officer and director
Sam Zaidspiner
Sam Zaidspiner
Co-Founder & CEO, director

Sources

  1. SECMedWatch Technologies, Inc. filing history
  2. CompanyMedWatch Technologies team